Ischemic Digital Ulcers Affect Hand Disability and Pain in Systemic Sclerosis

被引:55
作者
Mouthon, Luc
Carpentier, Patrick H.
Lok, Catherine
Clerson, Pierre
Gressin, Virginie
Hachulla, Eric
Berezne, Alice
Diot, Elisabeth
Van Kien, Aurelie Khau
Jego, Patrick
Agard, Christian
Duval-Modeste, Anne Benedicte
Sparsa, Agnes
Puzenat, Eve
Richard, Marie-Aleth
机构
[1] Univ Paris 05, Hop Cochin, APHP, Fac Med,Serv Med Interne,Ctr Reference Vasc Necro, Paris, France
[2] CHU Grenoble, Serv Med Vasc, F-38043 Grenoble, France
[3] CHU Amiens, Hop Sud, Serv Dermatol, Amiens, France
[4] Orgametrie, Roubaix, France
[5] Univ Lille 2, Hop Claude Huriez, Serv Med Interne, Ctr Reference Sclerodermie Syst, Lille, France
[6] Hop Bretonneau, Serv Med Interne, Tours, France
[7] Hop St Eloi, Serv Med Interne, Montpellier, France
[8] Hop Sud, Serv Med Interne, Rennes, France
[9] Ctr Hosp Univ Hotel Dieu, Serv Med Interne, Nantes, France
[10] Ctr Hosp Univ, Hop Charles Nicolle, Serv Dermatol, Rouen, France
[11] CHU Limoges, Hop Dupuytren, Serv Dermatol, Limoges, France
[12] Hop St Jacques, F-25030 Besancon, France
[13] Univ Aix Marseille, Hop Timone,UMR 911, Assistance Publ Hop Marseille,INSERM CRO2 UMR 911, Ctr Rech Oncol Biol & Oncopharmacol,Serv Dermatol, Marseille, France
关键词
SYSTEMIC SCLEROSIS; DIGITAL ULCERS; HAND; DISABILITY; BOSENTAN; RESEARCH GROUP EUSTAR; HEALTH SURVEY; SCLERODERMA; QUESTIONNAIRE; VALIDATION; BOSENTAN; REGISTRY; DISEASE; TRIALS; COHORT;
D O I
10.3899/jrheum.130900
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Ischemic digital ulcers (DU) are frequent and severe complications of systemic sclerosis (SSc). The purpose of our study was to assess the effect of DU on hand disability and pain in patients with SSc. Methods. The Evaluation of the Impact of Recurrent Ischemic DU on Hand Disability in Patients with SSc (ECLIPSE) is a prospective, multicenter, noninterventional study with a 2-year followup. Patients with SSc who experienced at least 1 DU in the previous year and received bosentan therapy were included between October 2009 and March 2011. This cohort is described at the time of inclusion. Results. There were 190 patients (132 females) from 53 centers. Mean age +/- SD was 43 +/- 15 years at SSc diagnosis and 53 +/- 15 years at inclusion. In 105 patients (56.2%). DU were the first non-Raynaud symptoms of SSc. The mean time interval between the occurrence of Raynaud phenomenon and the first DU episode was 6.6 +/- 9.1 years. The mean numbers of active DU and fingers affected per patient for both hands were 2.3 +/- 1.8 and 2.2 +/- 1.6, respectively. Presence of active DU at inclusion was significantly associated with pain and impaired hand function: Visual Analog Scale for pain (0 to 10) was 6.2 +/- 2.6 versus 2.5 +/- 2.4 (p < 0.0001) and Cochin Hand Function Scale for hand disability (0 to 90) was 38 +/- 20 versus 25 19 (p < 0.0001), respectively. Conclusion. DU represent a major sign of SSc, often affecting multiple fingers and both hands. They are significantly associated with pain and hand disability.
引用
收藏
页码:1317 / 1323
页数:7
相关论文
共 24 条
  • [1] Characteristics of Joint Involvement and Relationships with Systemic Inflammation in Systemic Sclerosis: Results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database
    Avouac, Jerome
    Walker, Ulrich
    Tyndall, Alan
    Kahan, Andre
    Matucci-Cerinic, Marco
    Allanore, Yannick
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1488 - 1501
  • [2] Impact of Systemic Sclerosis on Occupational and Professional Activity With Attention to Patients With Digital Ulcers
    Berezne, A.
    Seror, R.
    Morell-Dubois, S.
    de Menthon, M.
    Fois, E.
    Dzeing-Ella, A.
    Nguyen, C.
    Hachulla, E.
    Guillevin, L.
    Poiraudeau, S.
    Mouthon, L.
    [J]. ARTHRITIS CARE & RESEARCH, 2011, 63 (02) : 277 - 285
  • [3] Reliability and validity of the Duruoz Hand Index in the persons with systemic sclerosis (Scleroderma)
    Brower, LM
    Poole, JL
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (05): : 805 - 809
  • [4] Effect of sildenafil on digital ulcers in systemic sclerosis: analysis from a single centre pilot study
    Brueckner, Claudia S.
    Becker, Mike O.
    Kroencke, Thomas
    Huscher, Doerte
    Scherer, Hans Ulrich
    Worm, Margitta
    Burmester, Gerd
    Riemekasten, Gabriela
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) : 1475 - 1478
  • [5] Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry
    Denton, Christopher P.
    Krieg, Thomas
    Guillevin, Loic
    Schwierin, Barbara
    Rosenberg, Daniel
    Silkey, Mariabeth
    Zultak, Maurice
    Matucci-Cerinic, Marco
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (05) : 718 - 721
  • [6] Duruoz MT, 1996, J RHEUMATOL, V23, P1167
  • [7] European Medicines Agency, TRACL EUR PUBL ASS R
  • [8] Two faces of the same coin: Raynaud phenomenon and digital ulcers in systemic sclerosis
    Galluccio, Felice
    Matucci-Cerinic, Marco
    [J]. AUTOIMMUNITY REVIEWS, 2011, 10 (05) : 241 - 243
  • [9] Validation of french version of the Scleroderma Health Assessment Questionnaire (SSc HAQ)
    Georges, C
    Chassany, O
    Mouthon, L
    Tiev, K
    Toledano, C
    Meyer, O
    Marjanovic, Z
    Heneggar, C
    Papo, T
    Crickx, B
    Sereni, D
    Cabane, J
    Farge, D
    [J]. CLINICAL RHEUMATOLOGY, 2005, 24 (01) : 3 - 10
  • [10] Hachulla E, 2007, J RHEUMATOL, V34, P2423